Caiyi Cherry Li, Ph.D.
Dr. Li is a multi-disciplinary scientist with technical proficiency and theoretical knowledge of a wide variety of biological instrumentations. With advanced training in flow cytometry technology and applications, her primary responsibility at the core facility is to provide service in cell sorting, as well as consultation on various flow cytometry applications. Dr. Li's past research experience ranges from microbial pathogenesis to immunology. Her current research interest is tumor immunology.
1) microbial pathogenesis and vaccine development
2) epigenetic regulation of gene expression
3) immunology: T cell development and function
4) immunology: dendritic cell biology
5) flow cytometry
6) cancer immunology
Selected Key Publications
Suppression of dendritic cell-derived IL-12 by endogenous glucocorticoids is protective in LPS-induced sepsis.PloS Biol. 13(10): e1002269, 2015. [ Journal Article ]
- Nat Immunol. 7(7): 692-7, 2006. [ Journal Article ]
Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response.Genes Dev. 20(3): 282-96, 2006. [ Journal Article ]
- Mol Microbiol. 43(6): 1577-89, 2002. [ Journal Article ]
- Mol Microbiol. 35(1): 189-203, 2000. [ Journal Article ]
Dr. Li obtained her Ph.D. in biochemistry and molecular biology from University of Maryland, School of Medicine and completed her postdoctoral training at Howard Hughes Medical Institute, UCLA. She furthered her immunology training at NCI and joined the Laboratory of Genome Integrity's flow cytometry core facility in 2014.